ALS Flashcards

1
Q

What is ALS

A
  • rapidly progressive neurodegenerative disease of middle life that is rarely seen prior to age 40
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does ALS cause?

A
  • Disease of UMN and LMNs.
  • Loss of anterior horn cells in SC and the motor cranial nuclei in brainstem (LMN)
  • Demyelination and gliosis of corticospinal and corticobulbar tracts in motor cortex (UMN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Major signs - LMN

A

Muscle weakness, atrophy, fasciculations, hyporeflexia, muscle cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Major signs - UMN

A
  • spasticity, hyper-reflexia, pathological reflexes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Major signs - Bulbar signs

A
  • dysarthria, dysphagia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Major signs - Respiratory signs

A

Nocturnal respiratory difficulty, exertional dyspnea, accessory muscle use, paradoxical breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Major signs - Others

A
  • Fatigue, weight loss, cachexia, tendon shortening, contractures
  • Frozen shoulder (30% of persons with ALS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most frequent initial symptom

A
  • focal weakness beginning in the leg, arm, or bulbar muscles * No sensory symptoms initially
  • Cognition, extraocular eye movements and autonomic, bowel, bladder, and sexual functions usually remain intact initially
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ALS prognosis

A
  • Death usually results from respiratory failure with 50% of
    patients surviving 3-4 years after the onset of symptoms unless mechanical ventilation is used
  • Most die within 5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ALS Medications

A
  • Riluzole, is expensive and adds 2-3 months to a person’s life. Affects breathing function.
  • Radicava: unknown mechanism. Possibly anti-oxidant. Slowed decline in function in RCT in Japan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examination/Evaluation

A
  • MMT/Dynamometry (be sensitive)
  • Coordination
  • Tone
  • Balance
  • Fatigue
  • Psychosocial
  • ALSFRS (self grading ADLS)
  • ALSAG-40 and ALSAQ-5: well being, multiple domains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Consider the Multi-System Nature of the Disease during Examination

A
  • Autonomic Function
  • Sensory Function
  • Screen for cognitive impairments
  • Up to 13% can have fronto-temporal dementia; up to 50% with cognitive decline
  • Represents poorer prognosis
  • Screen for extrapyramidal signs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Symptoms of ALS

A
  • fatigue
  • muscle stiffness
  • muscle cramps
  • shortness of breath
  • sleep, pain, anxiety, depression, increased saliva, constipation
  • falls increasingly common with advancing disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treating fatigue

A

energy conservation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

f

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treating muscle stiffness and cramps

A

stretching

17
Q

treating pain

A
  • depends on source of pain
  • cramps: massage, stretch
  • skin pressure: positioning
  • Msk: P-AAROM and ex
18
Q

Treating falls

A
  • ADs, Orthotics, balance training
19
Q

what does highly repetitive or heavy resistance exercise cause?

A

prolonged loss of strength in weakened or denervated muscle

20
Q

what can excessive exercise cause?

A
  • impaired recovery of degenerated muscle fiber
21
Q

Pulmonary techniques

A
  • Inspiratory muscle training prolongs respiratory strength for FVC
  • mean length of survival increases
  • Lung volume recruitment training strongly enhances immediate cough efficacy with improved FVC
22
Q

overall considerations for exercise

A
  • ROM and stretching are accepted forms of exercise
  • Resistance of unaffected muscles and possibly muscles ≥ 3/5 using low to moderate load and intensity and aerobic ex at sub- maximal levels (50-65% of HRR) may be safe and effective
  • Aerobic and resistance ex more appropriate for early-mid stage and in those with slowly progressing disease.
  • Monitoring exercise load and tolerance is critical
  • Avoiding excessive fatigue and overwork damage
  • Instruct pts to not carry out activities to extreme fatigue
23
Q

Safety Considerations for overuse

A
  • Inability to perform daily activities following exercise due to exhaustion or pain
  • Reduction in maximal muscle force that gradually recovers
  • Increased or excessive cramping, soreness, fatigue or
    fasciculations
  • Keep an exercise log
  • Stop if overuse signs occur
24
Q

Stage I of ALS

A
  • Independent in ADLs. Ambulatory but clumsy. Specific group of muscles are mildly weak. Mostly doing education, energy conservation, home/workplace modification and psych support
  • Mild focal weakness, asymmetrical distribution, hand cramping possibly
  • Continue normal activities
  • Resistive strengthening for unaffected muscles;
  • Submaximal levels of activity otherwise.
25
Q

Stage II of ALS

A
  • Moderate weakness, still selective; slightly decreased independence
    now – climbing stairs, raising arms, buttoning etc.
  • May start to see some muscle wasting * Time to assess need for adaptive equipment, assistive devices, watch
    for falling.
  • Stretching and AROM exercise, strengthening of unaffected muscles,
  • Aerobic activities as he or she is able.
  • AAROM and PROM by caregivers/family of affected joints to minimize contracture formation
26
Q

Stage II ALS exercise considerations

A
  • Prevention of overuse fatigue and disuse atrophy.
  • Brief exercise several times throughout day with good time for rest.
  • 30-45 minutes of total exercise divided into 2-3 sessions.
  • Resistance, aerobic, active ex.
  • Active/resistive exercise may –> repetitive performance of functional activities
27
Q

Stage III (middle)

A
  • Ambulatory but with severe weakness in certain muscle groups: distal ankle and
    hand; mild to moderate limitation in function (should still be ambulatory)
  • Goal: keep physically independent.
  • Adaptive equipment
  • Begin respiratory therapy (deep breathing exercise)
28
Q

Adaptive Equipment for Stage III

A
  • AFO, powered chairs, splints for hands more typical
    wheelchair use for longer distances.
  • Possible head control difficulty with soft collar use indicated.
  • If disease is progressing rapidly, go with generic rather than custom equipment (save
    the patient $$)
  • Lightweight canes, rolling walker only
  • WC prescription (insurance probably only pays for 1 motorized device/wc)
29
Q

Stage IV (middle)

A
  • Severe weakness overall but with less weakness in UE. Wheelchair use. May be able to perform some ADLs. Likely see muscle wasting in LEs
  • PROM and AAROM exercises to prevent contractures.
  • Strengthening of any uninvolved muscles.
  • Education for skin inspection as a result of loss of functional mobility.
  • Sleep systems for pressure relief are indicated
30
Q

Stage V (Late)

A
  • Increasing and progressive weakness throughout.
  • Deteriorating mobility and endurance.
  • Constant wheelchair use.
  • Transfers require significant physical assist.
  • Decreased bed mobility requires additional assistance and repositioning to prevent pressure ulcers.
  • Pain may be an issue in immobilized joints. But pain may be due to spasticity, cramps too.
  • Likely significant head control issues exist. Head support is needed in order to eat, see, and breathe.
31
Q

Stage VI (late)

A
  • Confined to bed and requires maximal assistance with ADLs.
  • Proper postural support is needed in bed.
  • Frequent repositioning.
  • Pain management.
  • Progressive respiratory distress.
32
Q

Goal of Stage VI

A
  • Preserve vital functions through compensation
  • Prevent pressure sores, respiratory problems